ArticleMedicine2025
Total caffeine intake is associated with lower serum α-Klotho and may impact its detection accuracy: Evidence from NHANES 2007 to 2016 and molecular docking.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The relationship between total caffeine intake (TCI) and aging remains understudied. α-Klotho (KL), a key aging-related circulating biomarker, is clinically valuable. Unlike prior studies focusing on coffee intake, we analyzed TCI (from diet and supplements) to isolate its independent association with KL and explore mechanisms via molecular docking. We thus conducted a cross-sectional analysis with NHANES 2007 to 2016 data to investigate TCI and serum KL levels in adults aged 40 to 79. Serum KL levels were determined using ELISA kits, while trained interviewers assessed TCI through 24-hour dietary recalls. Generalized linear regression models were employed to evaluate the correlation between TCI and serum KL levels. We utilized restricted cubic spline analysis to explore the dose-response relationship between the 2 factors. Subgroup analyses and molecular docking studies were also conducted to further understand the association. After adjusting for potential confounders, higher TCI was significantly associated with lower serum KL levels. In the fully adjusted model, compared to the lowest TCI group, KL levels decreased by -30.21 pg/mL (95% CI = -50.49 to -9.93 pg/mL) and -27.31 pg/mL (95% CI = -51.94 to -2.67 pg/mL) in the third and fourth groups, respectively, indicating a significant trend (P for trend = .005). Restricted cubic spline analysis revealed a linear dose-response relationship (P for nonlinearity = .362). Subgroup analyses showed that the negative correlation was more pronounced in participants aged < 60 years, those who were overweight/obese, and females. Molecular docking analysis suggested a direct interaction between caffeine and KL, with a binding energy of -5.299 kcal/mol, implying a stable interaction. These results suggest a potential pro-aging effect of caffeine. Further prospective studies and experimental validation are needed to clarify caffeine's effects on KL. Notably, molecular docking indicates caffeine may interfere with α-Klotho immunoassay detection, emphasizing the need for caffeine abstinence before testing to enhance biomarker accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.